BRLS BRLS
Company Profile ↓Company Overview
BRLS (BRLS) is a publicly traded company listed on . The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Generates a return on equity of 98.7%, reflecting efficient use of shareholder capital.
Return on capital employed stands at 64.0%.
Recent Developments
- Dec 2025 Revenue of $31.48M (+8.2% YoY); net profit $-18.98M.
- Trailing 12 Months Year-on-year growth — revenue +8.2%.
- 5-Year Trend Long-term compounding — revenue CAGR 0.2%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 0.16% |
| 1 Year: | 8.16% |
Stock Price Performance
| 1 Year: | -69.00% |
| 6 Months: | -3.10% |
| 3 Months: | -45.49% |
| 1 Month: | -18.50% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)42.94 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Strong return on equity of 98.7%.
- Healthy ROCE of 64.0%.
CONS
- Trading 78.2% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | 6.83M | 8.26M | - | - | 5.48M | 8.08M | - | - | - | - | - |
| Gross Profit | - | 172.50M | 172.50M | - | - | -344.49K | -1.04M | -476.80K | - | 242.57K | 422.32K | 1.27M | - | 899.80K | 514.88K | 1.04M | 838.89K |
| Operating Income | -7.93K | - | -565.54K | -537.45K | -1.04M | -4.56M | -6.45M | -4.42M | - | -6.97M | -5.19M | -3.62M | - | -2.92M | -3.36M | -1.92M | -2.06M |
| Net Income | -7.30K | - | -551.18K | -287.55K | -227.26K | -5.94M | -8.30M | -6.59M | - | -8.43M | -6.30M | -4.83M | - | -4.19M | -4.60M | -3.78M | -3.51M |
| Diluted EPS | - | - | - | - | - | -0.55 | -0.77 | -0.61 | -2.56 | -0.49 | 0.29 | -0.23 | -1.25 | -0.20 | 0.21 | -0.18 | -0.16 |
| R&D Expense | - | - | - | - | - | 200.00K | 0 | 37.00K | - | 37.00K | 50.00K | 56.00K | - | 52.00K | 52.00K | 52.00K | 50.00K |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | - | - | 31.38M | 29.10M | 31.48M |
| Gross Profit | 172.50M | 175.95M | -1.30M | 2.19M | 3.51M |
| Operating Income | -428.38K | -2.89M | -19.95M | -20.40M | -11.04M |
| Net Income | -407.62K | -302.54K | -27.48M | -25.33M | -18.98M |
| Diluted EPS | - | - | -2.56 | -1.25 | -0.89 |
| R&D Expense | - | - | 460.00K | 197.00K | 202.00K |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Total Assets | 177.49M | 179.45M | 65.79M | 60.01M | 52.57M |
| Total Equity | 1.30M | 4.64M | -21.35M | -695.89K | -19.23M |
| Cash & Equivalents | 1.12M | 680.79K | - | - | 64.00K |
| Total Liabilities | - | - | 87.13M | 60.70M | 71.80M |
| Current Liabilities | 235.05K | 2.50M | 67.30M | 25.41M | 69.82M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | -602.16K | -2.11M | -18.01M | -15.09M | -6.60M |
| Investing Cash Flow | -175.95M | - | -4.47M | -1.91M | -65.74K |
| Financing Cash Flow | 177.68M | 1.66M | 24.94M | 10.03M | 6.08M |
| Capital Expenditure | - | - | -4.47M | -1.65M | - |
| Free Cash Flow | - | - | -22.47M | -16.74M | - |
| Share Buybacks | - | - | 159.45M | - | - |
Ratios (Annual)
Figures in %.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Gross Margin % | - | - | -4.2% | 7.5% | 11.2% |
| Operating Margin % | - | - | -63.6% | -70.1% | -35.1% |
| Net Margin % | - | - | -87.6% | -87.0% | -60.3% |
| ROE % | -31.3% | -6.5% | 128.7% | 3,639.6% | 98.7% |
| ROCE % | -0.2% | -1.6% | 1,314.7% | -59.0% | 64.0% |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for BRLS
Borealis Foods (Nasdaq: BRLS) amends 2025 annual report after going concern note - Stock Titan
<a href="https://news.google.com/rss/articles/CBMirAFBVV95cUxNVTlabF9CU0lONU9vOWtzQVl6S0NzcVNRVEJKTmVmYkc2NkRwVTNqQjNlTFZmVmxhWEJpZjNoWkpPa1c0MTVvc0VkMWZ2YUJyRmVvaTlwVTJxbHEzREttcERNVng0YXR4Ml9lRmhzaVNvSFdkemZvb2ptVjFkem5zdC1uTXMyMTRIVFZYOH…
Borealis Foods Inc. Secures $17 Million Term Loan Facility to Enhance Financial Flexibility and Support Operations - Quiver Quantitative
<a href="https://news.google.com/rss/articles/CBMi4wFBVV95cUxQR0RiTk05c0FNTHpocXN0YkFaay1TRUV2cEVBZ0hjM0p0Z3hlOUJrNU9CNnRkUF9sbVJRWHVCRUdJVWFYcXZ2T3prTG5XN3N3T2otWFh0bHNaS0ZabVdNZ283cmI3MlBnVF9TdEhJaGZwbWQ0dTRtbUZuZGZwbzd1ckxSSnltTTUwS1Ayc3…
Unusual volume stocks are being observed in Thursday's session. - ChartMill
<a href="https://news.google.com/rss/articles/CBMiswFBVV95cUxQenpETmJ6aHhwR2p0SDdNYW1jazI0c0Nwbm9XSndPU09VMVpDbHJza2lrWTgzY0MzZmo2elQxRE1wU0VKYUE5MFBZZ0w4NWlWN2JfZC1RU09rWkltWjFOZ011b1RuZzBjSlhxVUVzN2RzUmY5RFE1N3dTQkdhVmE4S3NGN0VUYzNCbl8tLW…
BRLS|Borealis Foods Inc|Price:0.738|Chg%:-0.082 - TradingKey
<a href="https://news.google.com/rss/articles/CBMibkFVX3lxTE1fblluWjg5cm1ZblhFMEd2UHg0aHpvM2dhMDlzbnRNbXJRVDQtX1Z0a2RCcC1USWdZaE9FMENNbEw1T0hPNkJabVEtUjUxZ2VRV0JrNjgwU3BxaUpwdTJBTE5ET2NFS3lGWUJQaU5R?oc=5" target="_blank">BRLS|Borealis Foods…
Borealis Foods Receives Nasdaq Noncompliance Delisting Warning - theglobeandmail.com
<a href="https://news.google.com/rss/articles/CBMi2wFBVV95cUxPX2JCQ1FHc3pyOGYtSVZFdXF3RkFUbndrUUV4S0J3azk4VW1Pa3RUTXU0NmNULXpGVzY4bFE0UkxTdGZ1NVctMUM2dWVxTmNvVVlBT3dCbFJGVGl5djNtOHZwVFd4WGRNR2JnbDBBNXdMRjFRWjJjM0NCNjEwaTBoR041V0poRjREa09NQW…
Late annual report puts Borealis Foods on Nasdaq clock until June 16 - Stock Titan
<a href="https://news.google.com/rss/articles/CBMiwAFBVV95cUxPRkw4WGtJU0gwTXl1WVh5MzFDX3FSdEMtb2RpQTBhSGNSUFhWMXhpQmQyazhOTDlob244cDRYOEJCRnI4Y2VQbkZwY2dxWWl1RTdKNjR4bmVkR2J1bVQ4VmJTbVZpTkhhMWNsWW1ReVZKZGZaMExhOWlETWppMHRvOEVtN25NekJwaVNjTz…
BRLS — Frequently Asked Questions
What is the current share price of BRLS?
As of 2026-08-05 17:25 PDT, BRLS trades at $0.87 on NASDAQ/NYSE. Its 52-week range is $0.65 to $4.01.
What is the P/E ratio of BRLS?
BRLS trades at a trailing price-to-earnings (P/E) ratio of -0.98.
What is the return on equity (ROE) of BRLS?
BRLS has a return on equity (ROE) of 98.69%. Its return on capital employed (ROCE) is 64.00%.
Is BRLS a good stock to buy?
This page provides a data-driven analysis of BRLS, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.